wire - news in brief

« BACK

Economics/Business



Results 401 - 425 of 425.


Innovation - Economics / Business - 28.01.2011
European research consortium to pilot digital privacy solutions at university and secondary school
Preserving privacy in school community portal and privacy protecting electronic university course evaluation | Danish | Dutch | | Greek | Spanish | Swedish Frankfurt, Germany, 28 January 2011—T

Economics / Business - Pharmacology - 24.01.2011
Novartis announces agreement to acquire Genoptix, Inc. in all cash offer
Novartis to acquire Genoptix through an all cash tender offer at USD 25.00 per share Genoptix laboratory service offerings provide strategic fit with the current portfolio of companion diagnos

Economics / Business - Pharmacology - 15.12.2010
Novartis to become global leader in eye care, with agreement of 100% merger with Alcon
Novartis to become global leader in eye care, with agreement of 100% merger with Alcon Novartis Board of Directors unanimously approves merger for a value of USD 168 per Alcon share totaling USD 12&p

Health - Economics / Business - 03.12.2010
Representatives of the UN, NGOs and private sector discuss new approaches to achieving the Millennium Development Goals at the Novartis Foundation symposium
Representatives of the UN, NGOs and private sector discuss new approaches to achieving the Millennium Development Goals at the Novartis Foundation symposium Experts from North and South continue the

Pharmacology - Economics / Business - 30.09.2010
Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, reaches settlement agreement with US Attorney’s Office
Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, reaches settlement agreement with US Attorney's Office Novartis Pharmaceuticals Corporation reaches resolution with US Attorney's

Health - Economics / Business - 24.09.2010
Novartis obtains CHMP positive opinion for its investigational pre-pandemic influenza vaccine Aflunov to help protect against (H5N1) avian influenza
Novartis obtains CHMP positive opinion for its investigational pre-pandemic influenza vaccine Aflunov to help protect against (H5N1) avian influenza Aflunov contains the MF59 adjuvant which has been

Economics / Business - 23.09.2010

Economics / Business - 26.08.2010
Novartis completes 77% majority ownership of Alcon
Novartis completes 77% majority ownership of Alcon adding new growth platform in eye care to its leading healthcare portfolio Alcon strategically complements Novartis' portfolio, adding a world class

Economics / Business - Innovation - 04.06.2010

Economics / Business - Pharmacology - 26.02.2010
Shareholders approve all proposed resolutions of Novartis Board of Directors
Shareholders approve 14 th consecutive dividend increase to CHF 2.20 (+5%) per share for 2010, representing a payout of approximately 55% of net income from continuing operations, marking cont

Computer Science - Economics / Business - 25.02.2010
IBM researchers develop energy-efficient method to analyze the quality of data at record speeds
Seattle and Zurich, 25 February 2010—IBM (NYSE: IBM) Research today unveiled a breakthrough method based on a mathematical algorithm that reduces the computational complexity, costs, and energy usage for analyzing the quality of massive amounts of data by two orders of magnitude. This new method will greatly help enterprises extract and use the data more quickly and efficiently to develop more accurate and predictive models.

Innovation - Economics / Business - 22.01.2010
IBM Research sets new record in magnetic tape data density
Zurich, Switzerland, 22 January 2010—IBM researchers today announced they have demonstrated a world record in areal data density on linear magnetic tape — a significant update to one of the computer industry's most resilient, reliable and affordable data storage technologies. IBM demonstrates new record in magnetic tape data density.

Pharmacology - Economics / Business - 18.01.2010
Novartis providing equivalent of over USD 2.5 million in immediate emergency aid for victims of Haiti earthquake
Basel - Novartis Through its local organizations in countries throughout the region, Novartis is providing the equivalent of over USD 2.5 million in immediate emergency aid for victims of the recent earthquake in Haiti.

Economics / Business - Innovation - 13.01.2010
  2010 wird besser – vor allem aus Sicht des Transportwesens sowie von Banken und Versicherungen
Zurich - University of Zurich Schweizer Unternehmer blicken optimistisch ins neue Jahr: Vor allem Vertreter des Transportwesens, Dienstleister sowie Banken und Versicherungen erwarten ein verbessertes Wirtschaftsklima.

Economics / Business - Religions - 08.01.2010
Banken ohne moralischen Kompass
Zurich - University of Zurich Das moderne Finanzwesen hat sich von religiösen und moralischen Grundsätzen gelöst. Nicht so das «Islamic Banking».

Economics / Business - Religions - 08.01.2010
Muhammad als formidabler Risikomanager
Zurich - University of Zurich «Islamic Banking» ist kein Nischenprodukt mehr. Auch Schweizer Banken wie UBS und CS verfügen heute über Scharia-konforme Anlagemöglichkeiten.

Economics / Business - Health - 04.01.2010

Environment - Economics / Business - 22.12.2009
«Wir brauchen einen globalen Emissionshandel»
Zurich - University of Zurich Marc Chesney, Professor für Finance an der Universität Zürich, ist nicht begeistert über das Resultat der Klimakonferenz von Kopenhagen.

Economics / Business - Philosophy - 27.11.2009
’’Tackling the crisis with a new world economic ethics’’: experts debate at the Novartis Foundation Symposium in Basel, Switzerland
27.11.2009 / Basel - Novartis Basel, November 27, 2009 - The global financial crisis has brought chaos to economic activities worldwide - new discussions about values and morals are taking place more often and becoming increasingly intense.

Economics / Business - Pharmacology - 04.11.2009
Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan
04.11.2009 / Basel - Novartis Basel, November 4, 2009 - Novartis has reached an agreement to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co.

Pharmacology - Economics / Business - 03.11.2009
Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China
03.11.2009 / Basel - Novartis Additional USD 250 million invested in advanced technical R&D and manufacturing facility opening in Changshu, furthering economic development of Jiangs